Benzinga | Aug 5, 2021 07:29AM EDT

Ironwood Pharmaceuticals Q2 EPS $0.34 Beats $0.22 Estimate, Sales $104.03M Beat $93.10M Estimate

Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.22 by 54.55 percent. This is a 112.5 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $104.03 million which beat the analyst consensus estimate of $93.10 million by 11.74 percent. This is a 16.32 percent increase over sales of $89.43 million the same period last year.